Introducing Clinician-Researcher Peter Anderson, MD, PhD
New staff pediatrician is nationally renowned for osteosarcoma expertise
AT A GLANCE
Background in brief:Staff, Department of Pediatric Hematology, Oncology and Blood & Marrow Transplantation
Appointment: Practiced at University of Texas MD Anderson Cancer Center, where he was section chief of non-neural solid tumors, and Mayo Clinic, where he launched the pediatric bone marrow transplant program. Medical degree from Mount Sinai School of Medicine. Residency in both internal medicine and pediatrics at Duke; fellowship in pediatric hematology-oncology at University of Minnesota
Research: >120 peer-reviewed publications, most notably on immune therapies and bone-seeking radiopharmaceuticals as targeted agents for osteosarcoma. Principal investigator on numerous studies,
including two very large (>200 patients) osteosarcoma and Ewing sarcoma immunotherapy trials. Currently studying how to boost effectiveness of radiation treatment with new medications
IN HIS OWN WORDS
Proudest discovery: “In the 1990s, I became discouraged about a chemotherapy side effect, mouth sores. After studying how glutamine heals mucosal tissue, I discovered that by putting glutamine in a sugar suspension, it could promote mucosal healing during chemotherapy. With help from several colleagues, my discovery became a commercial enterprise, Healios Products, which now distributes the glutamine disaccharide powder to cancer patients — and it is free for children.”
Why he joined Cleveland Clinic Children’s: “I moved to Cleveland to work again with Johannes Wolff, MD, with whom I collaborated on difficult cases and targeted therapy while at MD Anderson.” [Dr.Wolff joined Cleveland Clinic Children’s in 2013 as Chair of Pediatric Hematology, Oncology and Blood & Marrow Transplantation.] I also want to help families of children with cancer have more outpatient therapy — and be able to sleep in their own beds.
Collaborating with Taussig Cancer Institute: “Only 5 percent of cancer cases are in children, so the best new childhood cancer treatments will develop from adult cancer treatments. It’s a major advantage to
be in an organization like Cleveland Clinic that provides both pediatric and adult cancer care, and where physicians can collaborate to do cutting-edge research. In this way, children can also benefit from advances coming out of Cleveland Clinic’s Taussig Cancer Institute.My solid tumor group will both participate in Dr. Wolff’s pediatric targeted therapy program and work regularly with Taussig Cancer Institute colleagues.”
Patient care: My focuses include improving communication with patients and families. We sometimes assume that families comprehend and remember most of what we tell them. To reinforce better understanding, I often provide a flash drive with files that include a one-page summary of their condition, key contact information, a personalized treatment calendar, images of their CT or PET scans (so they can visualize the tumor) and articles to help them become experts on the condition. These resources help to educate and guide families.”
Physicians can reach Dr. Anderson at firstname.lastname@example.org or 216.445.4044.